NEW YORK (AP) — The latest on developments in financial markets (all times local):
4 p.m.
Stocks ended a wobbly day of trading mostly lower on Wall Street as a three-day winning streak stalled.
Facebook led losses among communications companies Thursday with a 1.8 percent drop after the New York Times reported that its data-sharing practices are now under criminal investigation.
Health care stocks fell. Pfizer gave up 2 percent.
Dollar General slumped 7.5 percent after reporting weak results.
Tailored Brands, which owns Men's Wearhouse, plunged 25 percent after giving investors a surprisingly weak first-quarter forecast.
The S&P 500 slipped 2 points, or 0.1 percent, to 2,808.
The Dow Jones Industrial Average edged up 7 points, less than 0.1 percent, to 25,709. The Nasdaq fell 12 points, or 0.2 percent, to 7,630.
Bond prices fell. The yield on the 10-year Treasury rose to 2.62 percent.
___
11:45 a.m.
Stocks shook off a wobbly start and were moving slightly higher in midday trading on Wall Street.
Banks, technology and industrial companies were leading the gains Thursday.
Apple rose 1 percent, JPMorgan Chase climbed 1.3 percent and General Electric added 3.2 percent.
Dollar General slumped 9.3 percent after reporting weak quarterly results.
The S&P 500 index rose 3 points, or 0.1 percent, to 2,814.
The Dow Jones Industrial Average rose 35 points, or 0.1 percent, to 25,737. The Nasdaq rose 3 points, or 0.1 percent, to 7,647.
Bond prices fell. The yield on the 10-year Treasury rose to 2.62 percent.
___
9:35 a.m.
Stock indexes are little changed in early trading on Wall Street as the market cools down after rising for three days in a row.
Gains for technology and industrial companies early Thursday were offset by losses elsewhere.
Apple rose 1 percent and General Electric added 4.5 percent. Dollar General lost 7.7 percent.
The S&P 500 index edged down 1 point to 2,809.
The Dow Jones Industrial Average edged up 27 points, or 0.1 percent, to 25,728. The Nasdaq slipped 6 points, or 0.1 percent, to 7,637.
Bond prices fell. The yield on the 10-year Treasury rose to 2.62 percent.
Before you consider Pfizer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.
While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
